Changes for page Neurodiagnoses
Last modified by manuelmenendez on 2025/03/03 22:46
From version 24.1
edited by manuelmenendez
on 2025/01/29 18:46
on 2025/01/29 18:46
Change comment:
There is no comment for this version
To version 27.1
edited by manuelmenendez
on 2025/01/29 18:48
on 2025/01/29 18:48
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -15,7 +15,7 @@ 15 15 ((( 16 16 = What is this about and what can I find here? = 17 17 18 -= =**Overview** ==18 += **Overview** = 19 19 20 20 The //Tridimensional Diagnostic Framework// redefines CNS diseases can be classified and diagnosed by focusing on: 21 21 ... ... @@ -23,10 +23,6 @@ 23 23 * **Axis 2**: Molecular Markers (biomarkers). 24 24 * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system). 25 25 26 - 27 -[[For instance, neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]] 28 - 29 - 30 30 This methodology enables: 31 31 32 32 * Greater precision in diagnosis. ... ... @@ -37,6 +37,8 @@ 37 37 38 38 There have been described these 3 diagnostic axes: 39 39 36 +[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]] 37 + 40 40 * ((( 41 41 **Axis 1: Etiology** 42 42 ... ... @@ -84,6 +84,9 @@ 84 84 ))) 85 85 86 86 85 + 86 + 87 + 87 87 (% class="col-xs-12 col-sm-4" %) 88 88 ((( 89 89 {{box title="**Contents**"}}